Nonoperating Income (Expense) in USD of CORCEPT THERAPEUTICS INC from Q2 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Corcept Therapeutics Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2018 to Q3 2025.
  • Corcept Therapeutics Inc Nonoperating Income (Expense) for the quarter ending September 30, 2025 was $5.02M, a 20.8% decline year-over-year.
  • Corcept Therapeutics Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was $22.9M, a 0.17% decline year-over-year.
  • Corcept Therapeutics Inc annual Nonoperating Income (Expense) for 2024 was $24.5M, a 42.1% increase from 2023.
  • Corcept Therapeutics Inc annual Nonoperating Income (Expense) for 2023 was $17.3M, a 386% increase from 2022.
  • Corcept Therapeutics Inc annual Nonoperating Income (Expense) for 2022 was $3.56M, a 572% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)

CORCEPT THERAPEUTICS INC Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $22.9M $5.02M -$1.32M -20.8% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-04
Q2 2025 $24.3M $5.02M -$987K -16.4% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-31
Q1 2025 $25.3M $6.2M +$709K +12.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-05
Q4 2024 $24.5M $6.7M +$1.56M +30.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-26
Q3 2024 $23M $6.35M +$1.14M +21.8% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-04
Q2 2024 $21.8M $6M +$2.66M +79.4% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-31
Q1 2024 $19.2M $5.49M +$1.91M +53.4% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-05
Q4 2023 $17.3M $5.14M +$3.36M +189% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-26
Q3 2023 $13.9M $5.21M +$4.14M +387% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $9.78M $3.35M +$2.72M +431% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-29
Q1 2023 $7.06M $3.58M +$3.5M +4376% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $3.56M $1.78M +$1.71M +2368% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-26
Q3 2022 $1.85M $1.07M +$998K +1386% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $854K $630K +$520K +473% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $334K $80K -$195K -70.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $529K $72K Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $72K -$550K -88.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $110K -$900K -89.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $275K -$1.2M -81.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $622K -$726K -53.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $1.01M -$168K -14.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $1.47M +$374K +34.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2019 $1.35M +$589K +77.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $1.18M +$616K +110% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $1.1M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q3 2018 $759K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $562K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01

CORCEPT THERAPEUTICS INC Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $24.5M +$7.27M +42.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-26
2023 $17.3M +$13.7M +386% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-26
2022 $3.56M +$3.03M +572% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-26
2021 $529K Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.